A Study of HS269 in Patients With Advanced Solid Tumors

Clinical trial NCT05058352 · UNKNOWN

Trial details

NCT number: NCT05058352
Sponsor: Zhejiang Hisun Pharmaceutical Co. Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2021-10-01
Primary completion: 2022-10-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.